C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2004
11/18/2004	US20040229858 VLA-4 inhibitor compounds
11/18/2004	US20040229848 For therapy of non-insulin dependent diabetes
11/18/2004	US20040229847 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/18/2004	CA2524511A1 Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders
11/18/2004	CA2524508A1 3-carbonylaminothiophenes and their use as fungicides
11/18/2004	CA2524321A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/18/2004	CA2524274A1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	CA2524269A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	CA2521700A1 Piperidinyl- and piperazinyl-alkylcarbamate derivatives, preparation and therapeutic application thereof
11/18/2004	CA2521580A1 Chemical compounds
11/17/2004	EP1477544A2 Blue Light-emitting Compounds, Blue Light-emitting Polymers, Processes of Preparing the Blue Light-emitting Compounds and Luminescent Element Including the Blue Light-emitting Polymers
11/17/2004	EP1477478A2 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses.
11/17/2004	EP1477186A1 Antipruritics
11/17/2004	EP1476444A1 Heterocyclic compounds possessing affinity at 5ht1-type receptors and use thereof in therapy
11/17/2004	EP1476438A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/17/2004	EP1476437A1 Novel tetrazole derivative useful as herbicides
11/17/2004	EP1476434A2 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
11/17/2004	EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004	EP1476161A1 Piperidine and piperazine derivatives possessing affinity at 5ht-1 type receptors
11/17/2004	EP1476151A1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders
11/17/2004	EP1289980B1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/17/2004	EP1263727B1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
11/17/2004	EP1242413B1 Substituted 1,3,4-oxadiazoles and a method of reducing tnf-alpha levels
11/17/2004	EP1210333B1 p-Tolyl-heterocycles as herbicides
11/17/2004	EP1082321B1 Heterocyclic derivatives which inhibit factor xa
11/17/2004	EP0942732B1 Use of nk-1 receptor antagonists for treating movement disorders
11/17/2004	EP0942731B1 Use of nk-1 receptor antagonists for treating substance use disorders
11/17/2004	CN1547672A Ultrasonic doppler effect speed measurement
11/17/2004	CN1546472A Pyridyl alkane acid amides as cytostatics and immunosupressives
11/16/2004	US6818658 Treating obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
11/16/2004	US6818651 Antiinflammatory, antiasthmatic, skin, and autoimmune disorders; crohn*s disease, ulcerative colitis, conjuctivitis, multiple sclerosis, and rheumatoid arthritis; chronic obstructive pulmonary disease
11/16/2004	US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
11/16/2004	US6818262 Squarylium dyes
11/16/2004	CA2247164C Oxa- and thia-diazole muscarinic receptor antagonists
11/16/2004	CA2107008C Antiarrhythmic and cardioprotective substituted -1(2h)isoquinolines, process for their production, medicament containing them and their use for the production of a medicament for combating heart failures
11/11/2004	WO2004096948A1 Electron transport agents for organic electronic devices
11/11/2004	WO2004096796A1 Novel aniline derivatives, their manufacture and use as pharmaceutical agents
11/11/2004	WO2004096781A1 Use of derivatives of 2, 4-dihydro-[1,2,4]triazole-3-thione as inhibitors o fteh enzyme myeloperoxidase (mpo)
11/11/2004	WO2004096767A1 Sustituted indoline and indole derivatives
11/11/2004	WO2004096757A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
11/11/2004	WO2004096287A2 Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
11/11/2004	WO2004096286A2 Antiviral phosphonate analogs
11/11/2004	WO2004096236A2 Immunomodulator phosphonate conjugates
11/11/2004	WO2004096235A2 Anti-cancer phosphonate analogs
11/11/2004	WO2004096220A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
11/11/2004	WO2004096210A1 Acylated indoline and tetrahydroquinoline derivatives as hcv inhibitors
11/11/2004	WO2004096135A2 Inhibitors of akt activity
11/11/2004	WO2004096131A2 Inhibitors of akt activity
11/11/2004	WO2004096129A2 Inhibitors of akt activity
11/11/2004	WO2004096128A2 Hiv integrase inhibitors
11/11/2004	WO2004087690A3 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex
11/11/2004	WO2004078748A3 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
11/11/2004	WO2004072052A3 Isoxasole-containing thiourea inhibitors useful for treatment of varicella zoster virus
11/11/2004	WO2004043337A3 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
11/11/2004	WO2004026844A9 Methods and compositions of novel triazine compounds
11/11/2004	WO2003079973A3 Mitotic kinesin inhibitors
11/11/2004	WO2003059258A3 Compositions and methods for treating heart failure
11/11/2004	US20040225111 Therapy for osteoporosis
11/11/2004	US20040224997 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
11/11/2004	US20040224966 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/11/2004	US20040224960 Pharmaceutical compositions and methods for their use
11/11/2004	US20040224955 Viral polymerase inhibitors
11/11/2004	US20040224953 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/11/2004	US20040224952 e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight.
11/11/2004	US20040224950 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/11/2004	US20040224948 Novel substituted benzoxazines as integrin antagonists
11/11/2004	US20040224946 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
11/11/2004	US20040224939 Antibacterial agents
11/11/2004	US20040224875 Inhibitors of glutaminyl cyclase
11/11/2004	US20040223912 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/11/2004	US20040223909 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/11/2004	CA2524251A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
11/11/2004	CA2523677A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
11/11/2004	CA2523561A1 Substituted 1,4-diazepines and uses thereof
11/11/2004	CA2523336A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
11/11/2004	CA2523083A1 Antiviral phosphonate analogs
11/11/2004	CA2523020A1 Use of derivatives of 2, 4-dihydro-[1,2,4]triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo)
11/11/2004	CA2522809A1 Novel aniline derivatives, their manufacture and use as pharmaceutical agents
11/11/2004	CA2522431A1 Inhibitors of akt activity
11/11/2004	CA2522262A1 Inhibitors of akt activity
11/11/2004	CA2519840A1 Anti-cancer phosphonate analogs
11/10/2004	EP1475377A1 Derivatives of indole and their use as phosphodiesterase 4 inhibitors
11/10/2004	EP1475373A1 5,11-Dihydrodibenzo[b,e][1,4]-oxazepine derivatives as calcium channel antagonists
11/10/2004	EP1475372A1 Nile red type compound emitting red light, process for producing the same, and luminescent element utilizing the same
11/10/2004	EP1475371A1 1-substituted-1-aminomethyl-cycloalkane derivatives (= gabapentin analogues), their preparation and their use in the treatment of neurological disorders
11/10/2004	EP1474421A1 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
11/10/2004	EP1474415A1 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
11/10/2004	EP1474403A2 Urea derivatives and their use as vanilloid receptor antagonists
11/10/2004	EP1474399A1 Benzenesulfonamide derivatives as antipsychotic agents
11/10/2004	EP1474398A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of the same as pharmaceuticals
11/10/2004	EP1474389A2 Delta1-pyrrolines
11/10/2004	EP1474149A2 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
11/10/2004	EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
11/10/2004	EP1474140A1 2-oxazolamines and their use as 5-ht2b receptor antagonists
11/10/2004	EP1473995A1 Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol and their use as pesticide
11/10/2004	EP1261605B1 Benzoxazole derivatives as tnf and pde iv inhibitors
11/10/2004	CN1545700A Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
11/10/2004	CN1545513A Novel 2H -pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
11/10/2004	CN1545508A 1,2,4-trioxolane antimalarials
11/10/2004	CN1544420A Inhibition of raf kinase using substituted heterocyclic ureas

1 ... 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 ... 647